Communication Between EphrinB2 and EphB4 Within the Osteoblast Lineage

被引:57
|
作者
Martin, T. J. [1 ,2 ]
Allan, E. H. [1 ,2 ]
Ho, P. W. M. [1 ,2 ]
Gooi, J. H. [1 ,2 ]
Quinn, J. M. W. [4 ]
Gillespie, M. T. [3 ]
Krasnoperov, V. [5 ]
Sims, N. A. [1 ,2 ]
机构
[1] St Vincents Inst, Dept Med, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Fitzroy, Vic 3065, Australia
[3] St Vincents Inst, Dept Med, Prince Henrys Inst, Clayton, Vic 3168, Australia
[4] Univ Melbourne, Prince Henrys Inst, Clayton, Vic 3168, Australia
[5] Vasgene Therapeut, Los Angeles, CA 90033 USA
关键词
Osteoblast; Ephrins; PTHrP; Bone remodeling; BONE-FORMATION; GROWTH-FACTORS; RECEPTOR; REVERSE; CELL; OSTEOCLASTS; PTHRP; BETA;
D O I
10.1007/978-1-4419-1050-9_6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Members of the ephrin and Eph family are local mediators of cell function through largely contact-dependent processes in development and in maturity. Production of ephrinB2 mRNA and protein are increased by PTH and PTHrP in osteoblasts. Both a synthetic peptide antagonist of ephrinB2/EphB4 receptor interaction and recombinant soluble extracellular domain of EphB4 (sEphB4), which is an antagonist of both forward and reverse EphB4 signaling, were able to inhibit mineralization and the expression of several osteoblast genes involved late in osteoblast differentiation. The findings are consistent with ephrinB2/EphB4 signaling within the osteoblast lineage having a paracrine role in osteoblast differentiation, in addition to the proposed role of osteoclast-derived ephrinB2 in coupling of bone formation to resorption. This local regulation might contribute to control of osteoblast differentiation and bone formation at remodeling sites, and perhaps also in modeling.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [21] The expressions of EphB4 and ephrinB2 in lung adenocarcinomas: a high level of the EphB4 protein is associated with lymph node metastasis
    Li, Ji
    Sung, Yuejun
    Wang, Xiaoxia
    Wang, Jiandong
    Zhu, Yehang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3447 - 3452
  • [22] Parathyroid Hormone Increases EphrinB2/EphB4 of Osteoclast/Osteoblast Coupling Factor in Primary Hyperparathyroidism Model.
    Nagata, Yuki
    Imanishi, Yasuo
    Miyaoka, Daichi
    Hayashi, Noriyuki
    Maeda, Tomomi
    Emoto, Masanori
    Inaba, Masaaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S74 - S74
  • [23] 浅谈EphrinB2/ephB4在骨重建中的作用
    吴梓齐
    杨涛源
    王景云
    中华老年口腔医学杂志, 2014, 12 (03) : 184 - 187
  • [24] Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling
    Brar, Manpreet
    Cheng, Lingyun
    Yuson, Ritchie
    Mojana, Francesca
    Freeman, William R.
    Gill, Parkash S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (12) : 1668 - 1673
  • [25] Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion
    Zhou, Xuan
    Liu Xiaoli
    Xiao, Yajuan
    Zhang, Jinfang
    Huang, Bintao
    Du, Qingfeng
    BLOOD, 2013, 122 (21)
  • [26] The EphB4/ephrinB2 signaling; a potential targeted therapy for myeloma bone disease
    Pennisi, A.
    Ling, W.
    Li, X.
    Khan, S.
    Yaccoby, S.
    BONE, 2010, 47 : S269 - S269
  • [27] Cell adhesion to ephrinb2 is induced by EphB4 independently of its kinase activity
    Sakamoto, H
    Zhang, XQ
    Suenobu, S
    Ohbo, K
    Ogawa, M
    Suda, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (03) : 681 - 687
  • [28] EphrinB2/EphB4信号转导与肿瘤血管生成
    余健
    辛艳飞
    由振强
    宣尧仙
    生命的化学, 2011, 31 (06) : 849 - 851
  • [29] Blockade of Ephrin/EphB4 Signaling within the Osteoblast Lineage Reduces Osteoblast Differentiation and Mineralization
    Allan, E. H.
    Pompolo, S.
    Gooi, J. H.
    Gillespie, M. T.
    Sims, N. A.
    Krasnoperov, V.
    Martin, T. J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S253 - S253
  • [30] Endothelial ephrinB2/EphB4 signaling controls permeability of glioma blood vessels
    Erber, Ralf
    Eichelsbacher, Uta
    Powajbo, Violetta
    Djonov, Valentin
    Korn, Tobias
    Ullrich, Axel
    Vajkoczy, Peter
    CANCER RESEARCH, 2006, 66 (08)